1.Autoimmune Hemolytic Anemia Predominantly Associated with IgA Anti-E and Anti-c.
Young Ae LIM ; Moon Kyu KIM ; Bong Hak HYUN
Journal of Korean Medical Science 2002;17(5):708-711
A patient with warm autoimmune hemolytic anemia (AIHA) due to predominance of immunoglobulin A (IgA) with an Rh specificity, considered to be the first case in Korea, is described. A 13-yr-old male patient with severe hemolytic anemia showed a weak reactivity (1+) in the direct antiglobulin test (DAT) by using anti-IgG antiglobulin reagent. This finding, however, could not fully explain the patient's severe AIHA. When anti-IgA reagent was used for the DAT, strong reactivity (4+) was observed and free anti-E and anti-c autoantibodies were also detected by anti-IgA and anti-IgG reagents. The patient's hemoglobin began to rise with the administration of steroids. Because RBCs coated with multiple types of immunoglobulins are associated with more severe hemolysis than those only with IgG, the DATs using anti-IgA and other reagents are needed for the correct diagnosis when the result of DAT is not compatible with patient's clinical manifestations.
Adolescent
;
Anemia, Hemolytic, Autoimmune/diagnosis/*immunology
;
Antibody Specificity
;
Autoantibodies/*blood
;
Coombs' Test
;
Humans
;
Immunoglobulin A/*blood
;
Korea
;
Male
;
Rh-Hr Blood-Group System/immunology
2.Serological characteristics and transfusion efficacy evaluation in 61 cases of autoimmune hemolytic anemia.
Yang YU ; Xiao-Lin SUN ; Chun-Ya MA ; Xiao-Zhen GUAN ; Xiao-Juan ZHANG ; Lin-Fen CHEN ; Ke WANG ; Yuan-Yuan LUO ; Yi WANG ; Ming-Wei LI ; Yan-Nan FENG ; Shan TONG ; Shuai YU ; Lu YANG ; Yue-Qing WU ; Yuan ZHUANG ; Ji-Chun PAN ; Qian FEN ; Ting ZHANG ; De-Qing WANG
Journal of Experimental Hematology 2013;21(5):1275-1279
This study was aimed to analyze the serological characteristics, efficacy and safety of incompatible RBC transfusion in patients with autoimmune hemolytic anemia (AIHA). The patients with idiopathic or secondary AIHA were analyzed retrospectively, then the serological characteristics and the incidence of adverse transfusion reactions were investigated, and the efficacy and safety of incompatible RBC transfusion were evaluated according to the different autoantibody type and infused different RBC components. The results showed that out of 61 cases of AIHA, 21 cases were idiopathic, and 40 cases were secondary. 8 cases (13.1%) had IgM cold autoantibody, 50 cases (82.0%) had IgG warm autoantibody, and 3 cases (4.9%) had IgM and IgG autoantibodies simultaneously. There were 18 cases (29.5%) combined with alloantibodies. After the exclusion of alloantibodies interference, 113 incompatible RBC transfusions were performed for 36 patients with AIHA, total efficiency rate, total partial efficiency rate and total inefficiency rate were 56.6%, 15.1% and 28.3%, respectively. Incompatible RBC transfusions were divided into non-washed RBC group and washed RBC group. The efficiency rate, partial efficiency rate and inefficiency rate in non-washed RBC group were 57.6%, 13.0% and 29.4%, respectively. The efficiency rate, partial efficiency rate and inefficiency rate in washed RBC group were 53.6%, 21.4% and 25.0%, respectively. There was no significant difference of transfusion efficacy (P > 0.05) in two groups. Incompatible RBC transfusions were also divided into IgM cold autoantibody group and IgG warm autoantibody group. The efficiency rate, partial efficiency rate and inefficiency rate in IgM cold autoantibody group were 46.2%, 30.8% and 29.4%, respectively. The efficiency rate, partial efficiency rate and inefficiency rate in IgG warm autoantibody group were 56.7%, 13.4% and 29.9%, respectively. There was no significant difference of transfusion efficacy (P > 0.05 ) in two groups. Hemolytic transfusion reaction was not observed in all incompatible RBC transfusions. It is concluded that the same ABO type of non-washed RBC transfusion and O type washed RBC transfusion are all relatively safe for the AIHA patients with severe anemia after the exclusion of alloantibodies interference. There is no significant difference of transfusion efficacy in two groups. The same ABO type of non-washed RBC transfusion is more convenient and efficient than washed RBC transfusion, and excessive use of type O RBCs can also be avoided.
Adult
;
Aged
;
Aged, 80 and over
;
Anemia, Hemolytic, Autoimmune
;
diagnosis
;
immunology
;
therapy
;
Blood Grouping and Crossmatching
;
Erythrocyte Transfusion
;
Female
;
Humans
;
Isoantibodies
;
Male
;
Middle Aged
;
Treatment Outcome
;
Young Adult
3.Ceftriaxone Induced Immune Hemolytic Anemia: Detection of Drug-dependent Antibody by Ex-vivo Antigen in Urine.
Sin Young KIM ; Kyung Soon SONG ; Hyun Ok KIM ; Hwan Mo LEE
Yonsei Medical Journal 2002;43(3):391-394
There have been a few reported cases of immune hemolytic anemia induced by ceftriaxone. We encountered a patient with immune hemolytic anemia that seemed to be stimulated by a degradation product of ceftriaxone. The patient's direct antiglobulin test was positive only for C3d, and no ceftriaxone-dependent antibodies were detectable in the patient's serum. To demonstrate the presence of the ceftriaxone-induced antibodies, an ex-vivo antigen in urine was obtained from the patient. In addition, we prepared a 1 mg/mL suspension solution of ceftriaxone, and group AB serum as a complement source. Using several combinations of the above reactants, the indirect antiglobulin test was performed. Only the indirect antiglobulin test using the patient's serum with the ex-vivo urine antigen was found to be positive. Other combinations were not reactive. To our knowledge, this is the first reported case in Korea, in which the causative antibody appeared to be stimulated solely by a degradation product of ceftriaxone.
Anemia, Hemolytic, Autoimmune/*chemically induced/*diagnosis/immunology/urine
;
Antigens/urine
;
Case Report
;
Ceftriaxone/*adverse effects
;
Cephalosporins/*adverse effects
;
Coombs' Test
;
Human
;
Male
;
Middle Age
4.Ceftriaxone Induced Immune Hemolytic Anemia: Detection of Drug-dependent Antibody by Ex-vivo Antigen in Urine.
Sin Young KIM ; Kyung Soon SONG ; Hyun Ok KIM ; Hwan Mo LEE
Yonsei Medical Journal 2002;43(3):391-394
There have been a few reported cases of immune hemolytic anemia induced by ceftriaxone. We encountered a patient with immune hemolytic anemia that seemed to be stimulated by a degradation product of ceftriaxone. The patient's direct antiglobulin test was positive only for C3d, and no ceftriaxone-dependent antibodies were detectable in the patient's serum. To demonstrate the presence of the ceftriaxone-induced antibodies, an ex-vivo antigen in urine was obtained from the patient. In addition, we prepared a 1 mg/mL suspension solution of ceftriaxone, and group AB serum as a complement source. Using several combinations of the above reactants, the indirect antiglobulin test was performed. Only the indirect antiglobulin test using the patient's serum with the ex-vivo urine antigen was found to be positive. Other combinations were not reactive. To our knowledge, this is the first reported case in Korea, in which the causative antibody appeared to be stimulated solely by a degradation product of ceftriaxone.
Anemia, Hemolytic, Autoimmune/*chemically induced/*diagnosis/immunology/urine
;
Antigens/urine
;
Case Report
;
Ceftriaxone/*adverse effects
;
Cephalosporins/*adverse effects
;
Coombs' Test
;
Human
;
Male
;
Middle Age